A unit of donated blood looks simple: a bag of red liquid that goes from a donor to a patient. Behind that is a layered system of laboratory checks, record matching and quality control. These steps are meant to make sure each unit is safe to transfuse and compatible with the person who receives it. Here is how that testing generally works, and why it matters.
Why every donation is tested
Blood is a biological product, and it can carry things a donor does not know about. A person may feel perfectly healthy and still have an infection in its early stages, or carry an antibody that could cause trouble for a recipient. Screening questions and a brief health check at the donation site catch many risks. Laboratory testing catches those that cannot be seen or reported.
Testing serves two separate goals. The first is safety: making sure the blood does not transmit infectious disease. The second is compatibility: making sure the blood suits the patient who will get it. Both happen before a unit is released for use, and both are repeated or confirmed at different points along the way.
Exact test panels differ between countries and blood services, because they depend on local disease patterns and national regulation. What follows describes the common principles rather than one specific programme.

What happens right after the donation
During collection, a few small tubes of blood are filled alongside the main bag. These sample tubes are labelled with the same unique identification number, usually a barcode, that appears on the bag. That number is the thread that links donor, donation, test results and final product, so labelling accuracy is treated as a critical control.
The bag and the sample tubes are then sent to a processing and testing laboratory. Many services separate the whole blood into its parts there, which you can read about in Red cells, plasma and platelets. Until the tests are complete, the units are held in quarantine, a status that means they cannot be issued to any hospital.
Temperature control matters during this stage too. How units are kept cool on the way is covered in Storage and transport.
Blood group and antibody testing
Every donation is typed to find its ABO group and its Rh (D) status. This is usually done twice in different ways: testing the red cells for the antigens they carry, and testing the plasma for the antibodies it holds. The two results should agree. If they do not, the unit is investigated and held back. A refresher on the groups themselves is in Blood types explained.

Laboratories also screen for unexpected antibodies. These are antibodies, often formed after pregnancy or an earlier transfusion, that react with red cell antigens outside the ABO system. A donor's antibodies can matter, especially in plasma and platelet products, and the findings guide how a unit is used.
Some donors may be typed more extensively, for example for additional antigens, so that closely matched blood can be offered to patients who need repeated transfusions, such as people with sickle cell disease.
Screening for infections
The infectious disease panel is the part most people think of. Samples are tested for markers of the infections that blood can transmit. Typically these include HIV, hepatitis B, hepatitis C and syphilis, and often others such as HTLV, depending on local requirements. Some regions add tests for infections like malaria, Chagas disease, West Nile virus or hepatitis E where they are relevant.
Two kinds of test
- Serological tests look for antibodies the body makes in response to an infection, or for pieces of the germ itself (antigens).
- Nucleic acid tests (NAT) look directly for the genetic material of a virus. Because they can detect infection earlier than antibody tests, they shorten the so-called window period.
The window period is the time between catching an infection and the point where a test can detect it. No test removes this gap entirely, which is why donor questions about recent travel, health and risk exposures remain an essential part of safety, not a formality.

Testing is one barrier among several. Donor selection, laboratory screening, processing and careful record keeping work together, and none is meant to carry the whole load alone.
What happens when a result is abnormal
If a screening test is reactive, the unit is not used. Often the result is first repeated, and further confirmatory tests are performed, because screening tests are designed to be very sensitive and can occasionally react when there is no true infection. Regardless of the outcome of the repeat, the original donation stays out of the supply unless the process clears it according to strict rules.
Donors with confirmed results are usually notified confidentially and advised to seek medical follow-up, and they may be deferred from donating. Services handle these conversations with care, because the news can be unexpected and distressing. Donating blood is not a substitute for a health check, and people worried about a possible exposure should get tested through a clinic rather than by donating.
Release, labelling and final checks
Only when all required tests are complete and the results are acceptable does a unit change status from quarantine to released. A computer system typically enforces this: it will not allow labels to be printed or stock to be issued if anything is missing or inconsistent. Labels show the blood group, product type and expiry date, and a second person or automated check often verifies them.
Hospitals then run their own tests before transfusion. A patient's sample is typed and screened for antibodies, and a crossmatch checks that the patient's plasma does not react with the donor's red cells. This final step is a last safeguard against incompatible blood.
Records are kept so a unit can be traced from donor to recipient and back again. If a problem is discovered later, for instance if a donor develops an infection soon after giving, other products from that donation can be found and withdrawn quickly.
What this means for donors
For a donor, the practical takeaway is that the small tubes taken at donation have a large job. Being honest during screening, keeping contact details current and following any follow-up advice all help the system work as intended. The testing is unseen by most people, but it is a major reason a transfusion can be given with confidence.